• Get Directions
  • Blog
  • Referring Physicians
  • (503) 245-1525
logo
  • Home
  • Active Studies
    • Alopecia Areata (Hair Loss)
    • Chronic Hives
    • Atopic Dermatitis (Eczema)
    • Psoriasis
    • Vitiligo
    • All Active Studies
  • Conditions We Study
    • Eczema (Atopic Dermatitis)
    • Psoriasis
    • Vitiligo
    • Hair Loss (Alopecia)
    • Actinic Keratoses
    • Seborrheic Dermatitis
    • Seborrheic Keratosis
    • Hidradenitis Suppurativa
    • Lichen Planus
    • Onychomycosis (Fungal Infection of the Nails)
    • Rosacea
    • Hyperhydrosis (Excessive Sweating)
    • Chronic Spontaneous Urticaria (Chronic Hives)
    • Frown Lines
  • Why Participate?
  • FAQ
  • About Us
    • Our Story
    • Research Team
    • Benjamin Ehst, MD, PhD
    • Jason Hawkes, MD, MS
    • Robert Matheson, MD
  • Sponsors
    • Why OMRC?
    • Completed Clinical Trials
    • News & Publications
  • Contact Us
  • Get Directions
  • Blog
  • Referring Physicians
  • (503) 245-1525

February 9, 2022Articles

Two new therapies approved for the treatment of atopic dermatitis

February 9, 2022Articles

Dr. Andrew Blauvelt named as one of the world’s most influential scientists

August 10, 2021Articles

The Psoriasis Pipeline

December 23, 2020Articles

A Study Patient’s Perspective on Psoriasis

March 5, 2020Articles

Clinical Trial Evaluating New Eczema Drug Shows Promising Results

February 4, 2020Articles

Relief for Genital Psoriasis

October 16, 2019Articles

Comparison study shows efficacy of new targets

December 11, 2018Articles

New “botox” delivers!

October 15, 2018Articles

Ilumya is now available!

August 7, 2018Articles

New treatment approved for excessive sweating!

Loading…

RESEARCH EXCELLENCE & PERSONALIZED PATIENT CARE

HomeActive StudiesConditions We StudyWhy Participate?FAQSponsorsTermsPrivacy PolicyContact

1750 S Harbor Way, Suite 330 – Portland, Oregon 97201

Copyright © 2024 Oregon Medical Research Center. All Rights Reserved.

LuxSci helps ensure HIPAA-Compliance for email and web services.